A new analysis of a large data set compiled by Kaiser Permanente suggests that combining PSA data with genetic risk data may offer a much more effective way to assess risk for clinically significant prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: genomics, gentics, Management, PSA, risk, strategy | 8 Comments »
The heading above is the first part of the title of a paper to be presented by Lilja et al. at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. The data from this study needs to be seen in conjunction with data presented just the other day by Vickers. … READ MORE …
Filed under: Diagnosis, Management, Prevention, Risk | Tagged: Management, PSA, rational, risk, screening, strategy, testing | 11 Comments »
